Research progress in gemcitabine intravesical perfusion and postoperative care after bladder cancer surgery / 国际生物医学工程杂志

ABSTRACT

Bladder tumors are one of the most common tumors of the urinary system, accounting for the highest morbidity and mortality rates of urological tumors in China, and the recurrence rate of postoperative tumors is also high. In recent years, bladder instillation of gemcitabine after bladder cancer surgery has been started in clinical practice. In this review, the dose, infusion method, and treatment time of commonly used bladder infusions of gemcitabine were summarized, the advantages of gemcitabine for postoperative bladder infusion in bladder cancer were reviewed, and the care related to the process of bladder infusion and the management of related complications were discussed.